Recalls & Warnings September 10, 2014 Seller of Joint Pain Supplement Warned for Drug Claims On August 24, 2014, the FDA issued a warning letter to CreAgri, Inc., following a website review, which found statements made about the company's products, including Olivenol plus Easeflex, Olivenol plus Essence Capsules, and Olivenol plus Essence Elixer, to be drug claims
Trial design and data sharing of standardized protocol elements and outcomes should be encouraged to support reproducibility of outcomes and meta-analysis
They only work because of the diet they come with
If you are on medication or a supplement regimen for any other health condition
Current evidence does not support the routine use of antibiotics for ASD treatment